UK geriatric medicine market is projected to grow at a significant CAGR during the forecast period. Geriatric medicine is one of the largest specialties in the UK. It offers a thought-provoking intellectual challenge, which includes illness that presents in unusual ways in older people. As per the European Geriatric Medicine Society, in 2019, the total population of the UK accounted for 66.4 million, in which, the %age of the population above 65 years estimated at 18.3%, whereas the %age of the population above 80 years estimated at 4.9%. Such a huge population base of elderly population, around 7.0 million, needs access to effective healthcare facilities.
A full report of UK Geriatric Medicine Market is available at: https://www.omrglobal.com/industry-reports/uk-geriatric-medicine-market
Therefore, the market players have a significant presence in UK for the geriatric healthcare solutions and services. Moreover, the Government of UK has a significant focus on improving the healthcare facilities for the elderly population base of the country. The Geriatric Medicine Programme by the Government of UK is further contributing to the development and demand for geriatric medicine in the country. Several academic institutes in the country are developing effective medicines for the geriatric population, offering growth to the geriatric medicine market in UK.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/uk-geriatric-medicine-market
Market Coverage
- Study Period- 2019-2026
- Base year- 2019
- Forecast period- 2020-2026
- Segments Covered- By Therapeutics and By Condition
- Key Companies Profiled- Novartis AG, GlaxoSmithKline Plc, Merck & Co. Inc., Sanofi SA, Pfizer Inc., Johnson & Johnson Services Inc., Boehringer Ingelheim GmbH, and AstraZeneca PLC
Key questions addressed by the report
- What is the market growth rate during the forecast period?
- Which segment dominates the market in the base year?
- Which segment will project the fastest growth in the market during the forecast period?
- How COVID-19 will impact the market growth in 2020 and coming years?
o Recovery Timeline
o Deviation from pre-COVID-19
o Most affected segment
o Recommendations
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
UK Geriatric Medicine Market – Segmentation
By Therapeutics
- Analgesic
- Anticoagulant
- Antihypertensive
- Antidiabetic
- Others (Statins and Antipsychotic)
By Condition
- Cardiovascular Diseases (CVDs)
- Diabetes
- Neurological
- Cancer
- Respiratory
- Others (Arthritis and Osteoporosis)
This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.
